AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of an advanced family of amino acid-based medical foods for the dietary management of several disorders of amino acid metabolism. These disorders include Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Isovalaric Acidemia (IVA), Homocystinurea (HCU) and Methylmalonic Acidemia (MMA)/Propionic Acidemia (PA).
Cambrooke Therapeutics is the first to offer a family of ready-to-drink, nutritionally complete formulas for inborn errors of metabolism: Phenactin AA Plus (PKU), Vilactin AA Plus (MSUD), Isovactin AA Plus (IVA), Homactin AA Plus (HCU) and Promactin AA Plus (MMA/PA). Each of these formulas provides for a patient’s daily protein needs in a new format and with unique benefits.
Most ready-to-drink formulas for these conditions have a harsh, high acid taste that lingers well after being consumed. This innovative family of formulas overcomes this problem by providing a mild, low-acid flavor. The formulas also include essential fatty acids and DHA to support brain and eye development and enhance bone health with an optimized Bone Health Blend to help build and maintain healthy bones. In addition, the Cambrooke’s new products aid digestive health with specially selected pre-biotic fiber that contains the equivalent of 20 grams of protein in each convenient, ready-to-drink carton, complete with an all-natural berry flavor, free of all artificial flavors and colors.
Patients have already commented that these products taste great and feel milder than other ready-to-drink amino acid based formulas. In addition to the taste and texture benefits, the unique low acid formulation may be gentler on digestion and oral health compared to the more highly acidic amino acid-based formulas currently available.
Gabbi R. Lewis, a 13-year-old girl with HCU, commented, “I have recently tried the Homactin AA Plus formula, and, I have to say, the consistency is outstanding. Also the packaging makes it look less like medicine so I could take it to school and not have to worry about people asking questions.”
Gabbi’s mother, Karen Lewis, also shared, “Being a mother of two children born with HCU, I was excited to hear the news of a new HCU formula becoming available. My son (24), daughter (13) and I became even more excited after sampling the new Homactin. As a parent, I always hoped my kids could drink a formula that was not as acidic and chalky. We think Homactin fulfills these wishes. With more of a milky consistency than a juice, it is smooth and doesn’t separate like the other products we have used.”
Cambrooke Therapeutics was founded by parents of two children with PKU who know first-hand the difficulty of managing serious medical disorders requiring a lifelong special diet. Cambrooke is committed to innovating great tasting therapeutic medical foods and low protein functional foods.
About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooketherapeutics.com.